ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2331

Assessment of the Likelihood of Joint Inflammation Recurrence in Previously Affected Joints During Psoriatic Arthritis Disease Course

Dafne Capelusnik1, Ori Elkayam2 and Mark Berman3, 1Tel Aviv Sourasky Medical Center, Ramat Gan, Israel, 2Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 3Tel Aviv Sourasky Medical Center, Kefar sava, Israel

Meeting: ACR Convergence 2024

Keywords: Disability, Epidemiology, physical examination, Psoriatic arthritis, Synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Psoriatic arthritis (PsA) is a chronic inflammatory disease that can cause joint pain, swelling, and stiffness. Patients often experience flares followed by periods of remission. Understanding the recurrence patterns can inform treatment strategies such as intra-articular injections and improve patient outcomes. The aim of this study was to investigate whether arthritis in PsA patients is more likely to recur in the same joint previously affected by the disease.

Methods: The study included PsA patients, who were under routine follow-up at the Tel
Aviv Medical Center Rheumatology Institute from 2016 to 2023. Data was obtained from the
TASMC data warehouse using MDClone software. Patients with at least 3 visits were
included. The medical chart of the Rheumatology Institute includes a “joint examination”
component, which allows to record consecutive test results of 68 swollen  joints as per
examiner opinion. Recurrence was defined as relapse of joint swelling during physical
examination, after absence of swelling for at least 6 months at the same joint. Missing
assessments were considered as absence of joint swelling. The association between baseline
joint swelling and recurrence was assessed in mixed-effects logistic regression models
adjusted for joint location and for visits during follow-up. Additionally, an interaction
analysis was done to determine the association of each different joint location. The most
frequent swollen joint at baseline (right knee) was used as reference joint. A sensitivity
analysis was performed including only joints with at least a 10% of swollen frequency at
baseline

Results: 492 patients were included, with a median (IQR) of 6 (4-9) follow-up visits. 44%
were male, with a mean (SD) age at baseline of 48 (15) years old, and a mean disease
duration of 1 year (1.9). 420 patients had at least 1 swollen joint at baseline, with a median
SJC of 2 (1-5). From 33456 joints assessed at baseline, 1402 were swollen (4.2%), and 514
(36.7%) of them recurred at least once during follow-up. The mixed model analysis showed
that baseline swelling at a specific joint was predictive for swelling during follow-up (OR
2.88 [95% CI 2.61-3.18, p< 0.001]) if the joint was swollen at baseline. This association was
different for each joint location, with the highest for ORs for left and right elbow (Figure 1), and it was
not modified by sex, age or disease duration. In a sensitivity analysis, when only considering
the most affected joints, baseline swelling remained predictive of recurrences, although the
association decreased (OR 1.51 [1.31-1.75], p< 0.001).

Conclusion: This study found a strong association between baseline joint swelling and
subsequent joint swelling episodes at the same joint in patients with PsA. This association
varied by joint location and remained significant even when considering only the most
frequently swollen joints. These findings suggest that baseline joint swelling can be a
valuable predictor of future disease activity in PsA. This may insinuate the presence of sub
clinical persistent inflammation in these joints suggesting the need for intra- articular anti-
inflammatory intervention in addition to systemic treatment.

Supporting image 1

Figure 1. Odds ratio of the interaction term between joint location and baseline swelling at the same joint. The right knee was used as the reference


Disclosures: D. Capelusnik: None; O. Elkayam: AbbVie/Abbott, 1, 6, Boehringer-Ingelheim, 6, Eli Lilly, 1, 6, Novartis, 1, 6, Pfizer, 1, 6; M. Berman: None.

To cite this abstract in AMA style:

Capelusnik D, Elkayam O, Berman M. Assessment of the Likelihood of Joint Inflammation Recurrence in Previously Affected Joints During Psoriatic Arthritis Disease Course [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/assessment-of-the-likelihood-of-joint-inflammation-recurrence-in-previously-affected-joints-during-psoriatic-arthritis-disease-course/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessment-of-the-likelihood-of-joint-inflammation-recurrence-in-previously-affected-joints-during-psoriatic-arthritis-disease-course/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology